Amgen Set to Buy Onyx Pharmaceuticals

Aug. 26 (Bloomberg) -- Bloomberg’s Drew Armstrong discusses the latest major pharmaceutical deal with Amgen set to purchase Onyx. He speaks with Stephanie Ruhle and Tom Keene on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)

Why BlueCrest Plans to Return Outside Money
14:36 - Michael Platt, who runs the $8 billion BlueCrest Capital Management, will return all client money and instead focus on managing his own wealth and that of his partners and employees. Bloomberg's Simone Foxman reports on "Bloomberg Markets." (Source: Bloomberg)
  • Global Business Report: Brazil Contraction, Banks Results
  • Car Sales Hot Month: Has Auto Loan Demand Peaked?
  • Fixed-Income Hit Hard: Trading Falls 22% in 3Q